{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:18:39Z","timestamp":1777951119482,"version":"3.51.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:00:00Z","timestamp":1682121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00213-023-06339-1","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T11:01:44Z","timestamp":1682161304000},"page":"1221-1234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic H3R activation reduces L-Dopa-induced dyskinesia, normalizes cortical GABA and glutamate levels, and increases striatal dopamine D1R mRNA expression in 6-hydroxydopamine-lesioned male\u00a0rats"],"prefix":"10.1007","volume":"240","author":[{"given":"Alberto","family":"Avila-Luna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"G\u00e1lvez-Rosas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Aguirre-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Hidalgo-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Alfaro-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Antonio","family":"Arias-Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0291-4554","authenticated-orcid":false,"given":"Antonio","family":"Bueno-Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,22]]},"reference":[{"key":"6339_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/BF00229879","volume":"89","author":"JE Aas","year":"1992","unstructured":"Aas JE, Laake JH, Brodal P, Ottersen OP (1992) Immunocytochemical evidence for in vitro release of glutamate and GABA from separate nerve terminal populations in the rat pontine nuclei. Exp Brain Res 89:540\u2013548","journal-title":"Exp Brain Res"},{"key":"6339_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/mds.1090","volume":"16","author":"JE Ahlskog","year":"2001","unstructured":"Ahlskog JE, Muenter MD (2001) Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:448\u2013458","journal-title":"Mov Disord"},{"key":"6339_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB (1989) The functional-anatomy of basal ganglia disorders. Trends Neurosci 12:366\u2013375","journal-title":"Trends Neurosci"},{"key":"6339_CR4","doi-asserted-by":"crossref","unstructured":"Andersson M, Hilbertson A, Cenci MA (1999) Striatal fosB expression is causally linked with L-Dopa-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease. Neurobiol Dis 6:461\u2013474","DOI":"10.1006\/nbdi.1999.0259"},{"key":"6339_CR5","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1046\/j.1460-9568.2000.00267.x","volume":"12","author":"OV Anichtchik","year":"2000","unstructured":"Anichtchik OV, Huotari M, Peitsaro N, Haycock JW, M\u00e4nnist\u00f6 PT, Panula P (2000) Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci 12:3823\u20133832","journal-title":"Eur J Neurosci"},{"key":"6339_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.bjp.0704053","volume":"133","author":"JA Arias-Monta\u00f1o","year":"2001","unstructured":"Arias-Monta\u00f1o JA, Floran B, Garcia M, Aceves J, Young JM (2001) Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of (3)H-gamma-aminobutryic acid from rat striatal slices. Br J Pharmacol 133:165\u2013171","journal-title":"Br J Pharmacol"},{"key":"6339_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.20296","volume":"57","author":"I Aubert","year":"2005","unstructured":"Aubert I, Guigoni C, Hakansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E (2005) Increased D-1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol 57:17\u201326","journal-title":"Ann Neurol"},{"key":"6339_CR8","doi-asserted-by":"crossref","unstructured":"Avila-Luna A, Rios C, Galvez-Rosas A, Montes S, Arias-Montano JA, Bueno-Nava A (2019) Chronic administration of the histamine H-3 receptor agonist immepip decreases L-Dopa-induced dyskinesias in 6-hydroxydopamine-lesioned rats. Psychopharmacol 236:1937\u20131948","DOI":"10.1007\/s00213-019-5182-y"},{"key":"6339_CR9","doi-asserted-by":"crossref","unstructured":"Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding YM, Brambilla R, Fisone G, Stoessl AJ, Bourdenx M, Engeln M, Navailles S, De Deurwaerdere P, Ko WKD, Simola N, Morelli M et al (2015) Pathophysiology of L-Dopa-induced motor and non-motor complications in Parkinson\u2019s disease. Prog Neurobiol 132:96\u2013168","DOI":"10.1016\/j.pneurobio.2015.07.002"},{"key":"6339_CR10","doi-asserted-by":"crossref","unstructured":"Berthet A, Porras G, Doudnikoff E, Stark H, Cador M, Bezard E, Bloch B (2009) Pharmacological analysis demonstrates dramatic alteration of D-1 dopamine receptor neuronal distribution in the rat analog of L-Dopa-induced dyskinesia. J Neurosci 29:4829\u20134835","DOI":"10.1523\/JNEUROSCI.5884-08.2009"},{"key":"6339_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/j.1471-4159.2011.07376.x","volume":"118","author":"S Bido","year":"2011","unstructured":"Bido S, Marti M, Morari M (2011) Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels. J Neurochem 118:1043\u20131055","journal-title":"J Neurochem"},{"key":"6339_CR12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bj\u00f6rklund","year":"2007","unstructured":"Bj\u00f6rklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194\u2013202","journal-title":"Trends Neurosci"},{"key":"6339_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/mds.870130507","volume":"13","author":"PJ Blanchet","year":"1998","unstructured":"Blanchet PJ, Konitsiotis S, Chase TN (1998) Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys. Mov Disord 13:798\u2013802","journal-title":"Mov Disord"},{"key":"6339_CR14","doi-asserted-by":"crossref","unstructured":"Blanchet PJ, Parent M-T, Rompre PH, Levesque D (2012) Relevance of animal models to human tardive dyskinesia. Behav Brain Funct 8:1\u20139","DOI":"10.1186\/1744-9081-8-12"},{"key":"6339_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuropharm.2015.08.013","volume":"106","author":"JP Bolam","year":"2016","unstructured":"Bolam JP, Ellender TJ (2016) Histamine and the striatum. Neuropharmacol 106:74\u201384","journal-title":"Neuropharmacol"},{"key":"6339_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0149-7634(96)00029-2","volume":"21","author":"P Calabresi","year":"1997","unstructured":"Calabresi P, Pisani A, Centonze D, Bernardi G (1997) Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum. Neurosci Biobehav Rev 21:519\u2013523","journal-title":"Neurosci Biobehav Rev"},{"key":"6339_CR17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/nn.3743","volume":"17","author":"P Calabresi","year":"2014","unstructured":"Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M (2014) Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci 17:1022\u20131030","journal-title":"Nat Neurosci"},{"key":"6339_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuroscience.2012.12.027","volume":"233","author":"C Capper-Loup","year":"2013","unstructured":"Capper-Loup C, Frey CM, Rebell D, Kaelin-Lang A (2013) Adaptive gene expression changes on the healthy side of parkinsonian rats. Neurosci 233:157\u2013165","journal-title":"Neurosci"},{"key":"6339_CR19","doi-asserted-by":"crossref","unstructured":"Carta M, Bezard E (2011) Contribution of pre-synaptic mechanisms to L-Dopa-induced dyskinesia. Neurosci 198:245\u2013251","DOI":"10.1016\/j.neuroscience.2011.07.070"},{"key":"6339_CR20","doi-asserted-by":"crossref","unstructured":"Cenci MA, Lee CS, Bjorklund A (1998) L-Dopa-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10:2694\u20132706","DOI":"10.1046\/j.1460-9568.1998.00285.x"},{"key":"6339_CR21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of parkinson disease a review. JAMA 311:1670\u20131683","journal-title":"JAMA"},{"key":"6339_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cne.902900109","volume":"290","author":"F Conti","year":"1989","unstructured":"Conti F, Defelipe J, Fari\u00f1as I, Manzoni T (1989) Glutamate-positive neurons and axon terminals in cat sensory cortex: a correlative light and electron microscopic study. J Comp Neurol 290:141\u2013153","journal-title":"J Comp Neurol"},{"key":"6339_CR23","doi-asserted-by":"publisher","first-page":"100612","DOI":"10.1016\/j.curtheres.2020.100612","volume":"93","author":"BO Dankyi","year":"2020","unstructured":"Dankyi BO, Amponsah SK, Allotey-Babington GL, Adams I, Goode NA, Nettey H (2020) Chitosan-coated hydroxypropylmethyl cellulose microparticles of levodopa (and Carbidopa): in vitro and rat model kinetic characteristics. Curr Ther Res 93:100612","journal-title":"Curr Ther Res"},{"key":"6339_CR24","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/brain\/awh290","volume":"127","author":"R De la Fuente-Fernandez","year":"2004","unstructured":"De la Fuente-Fernandez R, Sossi V, Huang ZG, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias. Brain 127:2747\u20132754","journal-title":"Brain"},{"key":"6339_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0301-0082(92)90015-7","volume":"39","author":"J DeFelipe","year":"1992","unstructured":"DeFelipe J, Fari\u00f1as I (1992) The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 39:563\u2013607","journal-title":"Prog Neurobiol"},{"key":"6339_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11064-006-9225-5","volume":"32","author":"A Diaz-Ruiz","year":"2007","unstructured":"Diaz-Ruiz A, Salgado-Ceballos H, Montes S, Maldonado V, Tristan L, Alcaraz-Zubeldia M, R\u00edos C (2007) Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats. Neurochem Res 32:57\u201363","journal-title":"Neurochem Res"},{"key":"6339_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cne.902900202","volume":"290","author":"I Dori","year":"1989","unstructured":"Dori I, Petrou M, Parnavelas JG (1989) Excitatory transmitter amino acid-containing neurons in the rat visual cortex: a light and electron microscopic immunocytochemical study. J Comp Neurol 290:169\u2013184","journal-title":"J Comp Neurol"},{"key":"6339_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cne.902910105","volume":"291","author":"E Elhanany","year":"1990","unstructured":"Elhanany E, White EL (1990) Intrinsic circuitry: synapses involving the local axon collaterals of corticocortical projection neurons in the mouse primary somatosensory cortex. J Comp Neurol 291:43\u201354","journal-title":"J Comp Neurol"},{"key":"6339_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tins.2014.02.007","volume":"37","author":"BA Ellenbroek","year":"2014","unstructured":"Ellenbroek BA, Ghiabi B (2014) The other side of the histamine H3 receptor. Trends Neurosci 37:191\u2013199","journal-title":"Trends Neurosci"},{"key":"6339_CR30","doi-asserted-by":"publisher","first-page":"15340","DOI":"10.1523\/JNEUROSCI.3144-11.2011","volume":"31","author":"TJ Ellender","year":"2011","unstructured":"Ellender TJ, Huerta-Ocampo I, Deisseroth K, Capogna M, Bolam JP (2011) Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. J Neurosci 31:15340\u201315351","journal-title":"J Neurosci"},{"key":"6339_CR31","doi-asserted-by":"publisher","first-page":"S497","DOI":"10.1002\/mds.22028","volume":"23","author":"S Fahn","year":"2008","unstructured":"Fahn S (2008) The history of dopamine and levodopa in the treatment of Parkinson\u2019s disease. Mov Disord 23:S497\u2013S508","journal-title":"Mov Disord"},{"key":"6339_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1258\/002367794780681697","volume":"28","author":"MF Festing","year":"1994","unstructured":"Festing MF (1994) Reduction of animal use: experimental design and quality of experiments. Lab Anim 28:212\u2013221","journal-title":"Lab Anim"},{"key":"6339_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jnr.1040","volume":"63","author":"A Gadea","year":"2001","unstructured":"Gadea A, L\u00f3pez-Colom\u00e9 AM (2001) Glial transporters for glutamate, glycine, and GABA: II. GABA transporters. J Neurosci Res 63:461\u2013468","journal-title":"J Neurosci Res"},{"key":"6339_CR34","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00213-019-05215-1","volume":"236","author":"A G\u00e1lvez-Rosas","year":"2019","unstructured":"G\u00e1lvez-Rosas A, Avila-Luna A, Vald\u00e9s-Flores M, Montes S, Bueno-Nava A (2019) GABAergic imbalance is normalized by dopamine D1 receptor activation in the striatum contralateral to the cortical injury in motor deficit-recovered rats. Psychopharmacol 236:2211\u20132222","journal-title":"Psychopharmacol"},{"key":"6339_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0306-4522(97)00100-0","volume":"80","author":"M Garcia","year":"1997","unstructured":"Garcia M, Floran B, Arias-Monta\u00f1o JA, Young JM, Aceves J (1997) Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H] GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neurosci 80:241\u2013249","journal-title":"Neurosci"},{"key":"6339_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.2147780","volume":"250","author":"CR Gerfen","year":"1990","unstructured":"Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429\u20131432","journal-title":"Science"},{"key":"6339_CR37","first-page":"109","volume":"3","author":"M Gonz\u00e1lez-Sep\u00falveda","year":"2013","unstructured":"Gonz\u00e1lez-Sep\u00falveda M, Rosell S, Hoffmann HM, Castillo-Ruiz MM, Mignon V, Moreno-Delgado D, Michel V, D\u00edaz J, Sabri\u00e1 J, Ortiz J (2013) Cellular distribution of the histamine H3 receptor in the basal ganglia: functional modulation of dopamine and glutamate neurotransmission. BG 3:109\u2013121","journal-title":"BG"},{"key":"6339_CR38","doi-asserted-by":"crossref","unstructured":"Guerriero RM, Giza CC, Rotenberg A (2015) Glutamate and GABA imbalance following traumatic brain injury. Curr Neurol Neurosci Rep 15: 1-11","DOI":"10.1007\/s11910-015-0545-1"},{"key":"6339_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10641969709080800","volume":"19","author":"DP Healy","year":"1997","unstructured":"Healy DP, O\u2019Rourke DA (1997) Regulation of dopamine-1A (D1A) receptor gene transcription. Clin Exp Hypertens 19:1\u201313","journal-title":"Clin Exp Hypertens"},{"key":"6339_CR40","doi-asserted-by":"crossref","unstructured":"Hely MA, Morris JGL, Reid WGJ, Trafficante R (2005) Sydney multicenter study of Parkinson\u2019s disease: non-L-Dopa-responsive problems dominate at 15 years. Mov Disord 20:190\u2013199","DOI":"10.1002\/mds.20324"},{"key":"6339_CR41","doi-asserted-by":"crossref","unstructured":"Huot P, Johnston TH, Koprich JB, Fox SH, Brotchie JM (2013) The pharmacology of L-Dopa-induced dyskinesia in Parkinson\u2019s disease. Pharmacol Rev 65:171\u2013222","DOI":"10.1124\/pr.111.005678"},{"key":"6339_CR42","doi-asserted-by":"crossref","unstructured":"Johansson PA, Andersson M, Andersson KE, Cenci MA (2001) Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-Dopa-induced dyskinesia. Neurobiol Dis 8:220\u2013239","DOI":"10.1006\/nbdi.2000.0372"},{"key":"6339_CR43","doi-asserted-by":"crossref","unstructured":"Jonkers N, Sarre S, Ebinger G, Michotte Y (2002) MK801 suppresses the L-Dopa-induced increase of glutamate in striatum of hemi-Parkinson rats. Brain Res 926:149\u2013155","DOI":"10.1016\/S0006-8993(01)03147-X"},{"key":"6339_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neuron.2008.11.005","volume":"60","author":"AC Kreitzer","year":"2008","unstructured":"Kreitzer AC, Malenka RC (2008) Striatal plasticity and basal ganglia circuit function. Neuron 60:543\u2013554","journal-title":"Neuron"},{"key":"6339_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.26082","volume":"30","author":"PA LeWitt","year":"2015","unstructured":"LeWitt PA (2015) Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics. Mov Disord 30:64\u201372","journal-title":"Mov Disord"},{"key":"6339_CR46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","volume":"15","author":"M Lundblad","year":"2002","unstructured":"Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease. Eur J Neurosci 15:120\u2013132","journal-title":"Eur J Neurosci"},{"key":"6339_CR47","doi-asserted-by":"crossref","unstructured":"Lundblad M, Usiello A, Carta M, H\u00e5kansson K, Fisone G, Cenci MA (2005) Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia. Exp Neurol 194:66\u201375","DOI":"10.1016\/j.expneurol.2005.02.002"},{"key":"6339_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1471-4159.1993.tb03165.x","volume":"60","author":"DL Martin","year":"1993","unstructured":"Martin DL, Rimvall K (1993) Regulation of \u03b3-aminobutyric acid synthesis in the brain. J Neurochem 60:395\u2013407","journal-title":"J Neurochem"},{"key":"6339_CR49","doi-asserted-by":"crossref","unstructured":"Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA (2007) Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson\u2019s disease. J Neurochem 101:483\u2013497","DOI":"10.1111\/j.1471-4159.2007.04456.x"},{"key":"6339_CR50","doi-asserted-by":"crossref","unstructured":"Mela F, Marti M, Bido S, Cenci MA, Morari M (2012) In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels. Neurobiol Dis 45:573\u2013582","DOI":"10.1016\/j.nbd.2011.09.015"},{"key":"6339_CR51","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0028-3908(01)00144-7","volume":"41","author":"A Molina-Hernandez","year":"2001","unstructured":"Molina-Hernandez A, Nunez A, Sierra JJ, Arias-Montano JA (2001) Histamine H-3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacol 41:928\u2013934","journal-title":"Neuropharmacol"},{"key":"6339_CR52","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1074\/jbc.M110.161489","volume":"286","author":"E Moreno","year":"2011","unstructured":"Moreno E, Hoffmann H, Gonzalez-Sepulveda M, Navarro G, Casado V, Cortes A, Mallol J, Vignes M, McCormick PJ, Canela EI, Lluis C, Moratalla R, Ferre S, Ortiz J, Franco R (2011) Dopamine D-1-histamine H-3 receptor heteromers provide a selective Link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286:5846\u20135854","journal-title":"J Biol Chem"},{"key":"6339_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.expneurol.2013.01.024","volume":"256","author":"N Morin","year":"2014","unstructured":"Morin N, Jourdain VA, Di Paolo T (2014) Modeling dyskinesia in animal models of Parkinson disease. Exp Neurol 256:105\u2013116","journal-title":"Exp Neurol"},{"key":"6339_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26103","volume":"30","author":"EV Mosharov","year":"2015","unstructured":"Mosharov EV, Borgkvist A, Sulzer D (2015) Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord 30:45\u201353","journal-title":"Mov Disord"},{"key":"6339_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/mol.116.104752","volume":"90","author":"G Nieto-Alamilla","year":"2016","unstructured":"Nieto-Alamilla G, M\u00e1rquez-G\u00f3mez R, Garc\u00eda-G\u00e1lvez A-M, Morales-Figueroa G-E, Arias-Monta\u00f1o J-A (2016) The histamine H3 receptor: structure, pharmacology, and function. Mol Pharmacol 90:649\u2013673","journal-title":"Mol Pharmacol"},{"key":"6339_CR56","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(13)62418-6","volume":"384","author":"JA Obeso","year":"2014","unstructured":"Obeso JA, Rodriguez-Oroz MC, Stamelou M, Bhatia KP, Burn DJ (2014) The expanding universe of disorders of the basal ganglia. Lancet 384:523\u2013531","journal-title":"Lancet"},{"key":"6339_CR57","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW et al (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord 32:1264\u20131310","journal-title":"Mov Disord"},{"key":"6339_CR58","first-page":"211","volume":"1","author":"E Olfert","year":"1993","unstructured":"Olfert E, Cross B, Mc William A (1993) Guide for the care and use of experimental animals. Can Council Anim Care 1:211","journal-title":"Can Council Anim Care"},{"key":"6339_CR59","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrn3526","volume":"14","author":"P Panula","year":"2013","unstructured":"Panula P, Nuutinen S (2013) The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 14:472\u2013487","journal-title":"Nat Rev Neurosci"},{"key":"6339_CR60","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0306-4522(89)90007-9","volume":"28","author":"P Panula","year":"1989","unstructured":"Panula P, Pirvola U, Auvinen S, Airaksinen MS (1989) Histamine-immunoreactive nerve-fibers in the rat-brain. Neuroscience 28:585\u2013610","journal-title":"Neuroscience"},{"key":"6339_CR61","doi-asserted-by":"crossref","unstructured":"Papathanou M, Rose S, McCreary A, Jenner P (2011) Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats. Eur J Neurosci 33:2247\u20132254","DOI":"10.1111\/j.1460-9568.2011.07704.x"},{"key":"6339_CR62","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejphar.2014.08.004","volume":"741","author":"M Papathanou","year":"2014","unstructured":"Papathanou M, Jenner P, Iravani M, Jackson M, Stockwell K, Strang I, Zeng B-Y, McCreary AC, Rose S (2014) The H-3 receptor agonist immepip does not affect L-Dopa-induced abnormal involuntary movements in 6-OHDA-lesioned rats. Eur J Pharmacol 741:304\u2013310","journal-title":"Eur J Pharmacol"},{"key":"6339_CR63","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn, Academic Press, San Diego"},{"key":"6339_CR64","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1073858402238515","volume":"8","author":"OAC Petroff","year":"2002","unstructured":"Petroff OAC (2002) GABA and glutamate in the human brain. Neuroscientist 8:562\u2013573","journal-title":"Neuroscientist"},{"key":"6339_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","volume":"114","author":"C Pillot","year":"2002","unstructured":"Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, Arrang JM (2002) A detailed mapping of the histamine H-3 receptor and its gene transcripts in rat brain. Neuroscience 114:173\u2013193","journal-title":"Neuroscience"},{"key":"6339_CR66","doi-asserted-by":"crossref","unstructured":"Porras G, De Deurwaerdere P, Li Q, Marti M, Morgenstern R, Sohr R, Bezard E, Morari M, Meissner WG (2014) L-Dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum. Sci Rep 4(1):3730","DOI":"10.1038\/srep03730"},{"key":"6339_CR67","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1523\/JNEUROSCI.18-06-02009.1998","volume":"18","author":"G Radnikow","year":"1998","unstructured":"Radnikow G, Misgeld U (1998) Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J Neurosci 18:2009\u20132016","journal-title":"J Neurosci"},{"key":"6339_CR68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pnpbp.2016.10.002","volume":"73","author":"M Rapanelli","year":"2017","unstructured":"Rapanelli M (2017) The magnificent two: histamine and the H3 receptor as key modulators of striatal circuitry. Prog Neuropsychopharmacol Biol Psychiatry 73:36\u201340","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6339_CR69","doi-asserted-by":"publisher","first-page":"21042","DOI":"10.1074\/jbc.M116.731406","volume":"291","author":"M Rapanelli","year":"2016","unstructured":"Rapanelli M, Frick LR, Horn KD, Schwarcz RC, Pogorelov V, Nairn AC, Pittenger C (2016) The histamine H3 receptor differentially modulates mitogen-activated protein kinase (MAPK) and Akt signaling in striatonigral and striatopallidal neurons. J Biol Chem 291:21042\u201321052","journal-title":"J Biol Chem"},{"key":"6339_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0006-8993(99)01779-5","volume":"841","author":"RL Reep","year":"1999","unstructured":"Reep RL, Corwin JV (1999) Topographic organization of the striatal and thalamic connections of rat medial agranular cortex. Brain Res 841:43\u201352","journal-title":"Brain Res"},{"key":"6339_CR71","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cne.10868","volume":"467","author":"RL Reep","year":"2003","unstructured":"Reep RL, Cheatwood JL, Corwin JV (2003) The associative striatum: organization of cortical projections to the dorsocentral striatum in rats. J Comp Neurol 467:271\u2013292","journal-title":"J Comp Neurol"},{"key":"6339_CR72","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbr.2012.09.047","volume":"237","author":"G Rui","year":"2013","unstructured":"Rui G, Guangjian Z, Yong W, Jie F, Yanchao C, Xi J, Fen L (2013) High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats. Behav Brain Res 237:263\u2013269","journal-title":"Behav Brain Res"},{"key":"6339_CR73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00001756-199401000-00022","volume":"5","author":"JH Ryu","year":"1994","unstructured":"Ryu JH, Yanai K, Iwata R, Ido T, Watanabe T (1994a) Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat-brain. Neuroreport 5:621\u2013624","journal-title":"Neuroreport"},{"key":"6339_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0304-3940(94)90279-8","volume":"178","author":"JH Ryu","year":"1994","unstructured":"Ryu JH, Yanai K, Watanabe T (1994b) Marked increase in histamine H3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: an autoradiographic study. Neurosci Lett 178:19\u201322","journal-title":"Neurosci Lett"},{"key":"6339_CR75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1476-5381.1996.tb15441.x","volume":"118","author":"JH Ryu","year":"1996","unstructured":"Ryu JH, Yanai K, Zhao X-L, Watanabe T (1996) The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones. Br J Pharmacol 118:585\u2013592","journal-title":"Br J Pharmacol"},{"key":"6339_CR76","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neulet.2004.04.045","volume":"364","author":"E S\u00e1nchez-Lemus","year":"2004","unstructured":"S\u00e1nchez-Lemus E, Arias-Monta\u00f1o JA (2004) Histamine H-3 receptor activation inhibits dopamine D-1 receptor-induced cAMP accumulation in rat striatal slices. Neurosci Lett 364:179\u2013184","journal-title":"Neurosci Lett"},{"key":"6339_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(08)60289-5","volume":"22","author":"A Schousboe","year":"1981","unstructured":"Schousboe A (1981) Transport and metabolism of glutamate and GABA in neurons are glial cells. Int Rev Neurobiol 22:1\u201345","journal-title":"Int Rev Neurobiol"},{"key":"6339_CR78","doi-asserted-by":"crossref","unstructured":"Spigolon G, Fisone G (2018) Signal transduction in L-Dopa-induced dyskinesia: from receptor sensitization to abnormal gene expression. J Neural Transm 125:1171\u20131186","DOI":"10.1007\/s00702-018-1847-7"},{"key":"6339_CR79","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","volume":"30","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ, Ding J, Day M, Wang Z, Shen W (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30:228\u2013235","journal-title":"Trends Neurosci"},{"key":"6339_CR80","doi-asserted-by":"crossref","unstructured":"Takei H, Yamamoto K, Bae Y-C, Shirakawa T, Kobayashi M (2017) Histamine H3 heteroreceptors suppress glutamatergic and GABAergic synaptic transmission in the rat insular cortex. Front Neural Circuits 11:1\u201318","DOI":"10.3389\/fncir.2017.00085"},{"key":"6339_CR81","first-page":"1","volume-title":"Handbook of Neurochemistry and Molecular Neurobiology: Amino Acids and Peptides in the Nervous System","author":"HS Waagepetersen","year":"2007","unstructured":"Waagepetersen HS, Sonnewald U, Schousboe A (2007) Glutamine, glutamate, and GABA: metabolic aspects. In: Lajtha A, Oja SS, Schousboe A, Saransaari P (eds) Handbook of Neurochemistry and Molecular Neurobiology: Amino Acids and Peptides in the Nervous System. Springer, US, Boston, MA, pp 1\u201321"},{"key":"6339_CR82","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2009.05.044","volume":"1280","author":"JH Wu","year":"2009","unstructured":"Wu JH, Corwin JV, Reep RL (2009) Organization of the corticostriatal projection from rat medial agranular cortex to far dorsolateral striatum. Brain Res 1280:69\u201376","journal-title":"Brain Res"},{"key":"6339_CR83","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12031-018-1116-0","volume":"65","author":"X Wu","year":"2018","unstructured":"Wu X, Xu F-l, Wang B-j, Yao J (2018) Analysis of the promoter region of human dopamine receptor D1. J Mol Neurosci 65:438\u2013443","journal-title":"J Mol Neurosci"},{"key":"6339_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/02699050500284218","volume":"24","author":"S Yoon","year":"2006","unstructured":"Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21\u201344","journal-title":"Growth Factors"},{"key":"6339_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neuint.2018.04.005","volume":"118","author":"X Zheng","year":"2018","unstructured":"Zheng X, Wu J, Zhu Y, Chen S, Chen Z, Chen T, Huang Z, Wei J, Li Y, Lei W (2018) A Comparative study for striatal-direct and -indirect pathway neurons to DA depletion-induced lesion in a PD rat model. Neurochem Int 118:14\u201322","journal-title":"Neurochem Int"},{"key":"6339_CR86","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/j.1471-4159.1992.tb11023.x","volume":"59","author":"Q-Y Zhou","year":"1992","unstructured":"Zhou Q-Y, Li C, Civelli R (1992) Characterization of gene organization and promoter region of the rat dopamine D1 receptor gene. J Neurochem 59:1875\u20131883","journal-title":"J Neurochem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06339-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06339-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T06:11:33Z","timestamp":1683785493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06339-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,22]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6339"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06339-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,22]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}